Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
1383980-52-6 | Bis-aminooxy-peg7 | AA019E9Z | MFCD30723215
2183440-32-4 | APN-C3-PEG4-azide | AA019EER
1004527-74-5 | tert-Butyl 4-(hydrazinecarbonyl)-4-methylpiperidine-1-carboxylate | AA019EI2 | MFCD30185053
1089724-08-2 | 4-(ethylamino)-2-(methylthio)-5-Pyrimidinecarboxylic acid | AA019EL6 | MFCD12911522
928215-97-8 | tert-Butyl 4-(4-chlorophenyl)-2-oxo-2,5-dihydro-1h-pyrrole-1-carboxylate | AA019EOE | MFCD24469255
1199590-77-6 | 2-((5-Bromo-3-cyanopyridin-2-yl)amino)acetamide | AA019ERS | MFCD30185092
1393102-03-8 | methyl 2-methyl-2-(3-methyl-4-nitro-1H-pyrazol-1-yl)propanoate | AA019EUP | MFCD23162010
174403-79-3 | Diethyl (4-fluorobenzoyl)malonate | AA019EY5 | MFCD29081542
40828-46-4 | Suprofen | AA019FQ0 | MFCD00079572
1283718-04-6 | tert-Butyl 3-(2,2,2-trifluoro-1-hydroxyethyl)piperidine-1-carboxylate | AA019G0N | MFCD18800771
257870-39-6
845781-51-3